AJP - Renal Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol (February 3, 2004). doi:10.1152/ajprenal.00386.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/F1178    most recent
00386.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Q.
Right arrow Articles by Hummler, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Q.
Right arrow Articles by Hummler, E.
Submitted on October 31, 2003
Accepted on January 27, 2004

Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under normal salt diet

Qing Wang1, Sophie Clement2, Giulio Gabbiani2, Jean-Daniel Horisberger3, Michel Burnier1, Bernard C Rossier3, and Edith Hummler3*

1 Division of Hypertension, University of Lausanne, Lausanne, Switzerland
2 Department of Pathology, University of Geneva, Geneva, Switzerland
3 Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland

* To whom correspondence should be addressed. E-mail: ehummler{at}pop-server.unil.ch.

Primary aldosteronism causes severe hypertension in human (Conn's syndrome) with cardiac hypertrophy, characterized by a fibrosis more severe than the one observed in patients with essential hypertension. This suggests that aldosterone by itself may have specific and direct effects on cardiac remodeling through the activation of the cardiac mineralocorticoid receptor. Experimental evidence obtained in studying uninephrectomized rats treated with aldosterone or deoxycorticosterone (DOC), together with salt loading has led to similar conclusions. To examine the direct consequences of chronically elevated aldosterone levels on cardiac pathophysiology, we analyzed a mouse model ({alpha}ENaC-/-Tg) that is normotensive under normal salt diet, but exhibits chronic hyperaldosteronism. 16 months old transgenic rescue mice which were kept under a regular salt diet that contains a small amount of sodium (0.3% Na+) displayed a compensated PHA-1 phenotype with normal body weight, normal kidney index, normal blood pressure, but 6.3 fold elevated plasma aldosterone levels compared to the agematched control group. Peripheral resistance of distal colon to aldosterone was shown by a significant decrease of the amiloride-sensitive rectal potential difference ([[DLETA]]PDamil) and its diurnal cyclicity was blunted. Despite chronically high plasma aldosterone levels, these animals do not show any evidence of cardiac hypertrophy, remodeling or fibrosis, using collagen staining and anti-{alpha}-skeletal and {alpha}-smooth actin immunochemical labeling of heart sections. Cardiac fibrosis as seen in DOC or aldosterone/salt-treated animal models is therefore likely to be due to the synergistic effect of salt, aldosterone and other confounding factors, rather than to the elevated circulating aldosterone levels alone.




This article has been cited by other articles:


Home page
 HypertensionHome page
B. Sontia, A. C.I. Montezano, T. Paravicini, F. Tabet, and R. M. Touyz
Downregulation of Renal TRPM7 and Increased Inflammation and Fibrosis in Aldosterone-Infused Mice: Effects of Magnesium
Hypertension, April 1, 2008; 51(4): 915 - 921.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J Manolopoulou, M Bielohuby, S J Caton, C E Gomez-Sanchez, I Renner-Mueller, E Wolf, U D Lichtenauer, F Beuschlein, A Hoeflich, and M Bidlingmaier
A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serum
J. Endocrinol., February 1, 2008; 196(2): 215 - 224.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. P. Ponda and T. H. Hostetter
Aldosterone Antagonism in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 668 - 677.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Lister, D. J. Autelitano, A. Jenkins, R. D. Hannan, and K. E. Sheppard
Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: A possible role for SGK1
Cardiovasc Res, June 1, 2006; 70(3): 555 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
R. Perrier, S. Richard, Y. Sainte-Marie, B. C. Rossier, F. Jaisser, E. Hummler, and J.-P. Benitah
A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice
J. Physiol., November 15, 2005; 569(1): 153 - 162.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Ouvrard-Pascaud, Y. Sainte-Marie, J.-P. Benitah, R. Perrier, C. Soukaseum, A. N. D. Cat, A. Royer, K. Le Quang, F. Charpentier, S. Demolombe, et al.
Conditional Mineralocorticoid Receptor Expression in the Heart Leads to Life-Threatening Arrhythmias
Circulation, June 14, 2005; 111(23): 3025 - 3033.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.